Presence of Dendritic Cells, MCP-1, and Activated Microglia/Macrophages in Amyotrophic Lateral Sclerosis Spinal Cord Tissue

Annals of Neurology

Volumn 55, Issue 2, 2004, Pages 221-235

  Henkel, Jenny S ^a   Engelhardt, Joseph I ^b   Siklós, László ^c   Simpson, Ericka P ^a   Kim, Seung H ^a   Pan, Tianhong ^a   Goodman, J Clay ^a   Siddique, Teepu ^d   Beers, David R ^a   Appel, Stanley H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN; CD83 ANTIGEN; CELL SURFACE MARKER; COLONY STIMULATING FACTOR 1; DEC205 ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SR A ANTIGEN; T6 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; FAMILIAL DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; MONOCYTE; MOTOR NERVE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CHEMOKINE CCL2; CYTOKINES; DENDRITIC CELLS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD;

EID: 10744229158     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10805     Document Type: Article

References (59)

1. Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 1993;50:30-36.
2. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992;140:691-707.
3. Troost D, Van den Oord JJ, Vianney de Jong JMB. Immunohistochemical characteristics of the inflammatory infiltration in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1990;16:401-410.
4. Lampson LA, Kushner PD, Sobel RA. Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann Neurol 1990;28:365-372.
5. Engelhardt JI, Appel SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol 1990;47:1210-1216.
6. Ince PG, Shaw PJ, Slade JY, et al. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol 1996;92:395-403.
7. McGeer PL, Itagaki S, McGeer EG. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol 1988;76:550-557.
8. Sasaki S, Shibata N, Komori T, Iwata M. iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci Lett 2000;291:44-48.
9. Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL. Marked increase in cyclooxygenase-2 in ALS spinal cord. Neurology 2001;57:952-956.
10. Grewal RP, Morgan TE, Finch CE. C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis. Neurosci Lett 1999;271:65-67.
11. Losy J, Michalowska-Wender G. Surface CD2, CD4, CD8 markers and IL-2 and TNF-alpha cytokines in amyotrophic lateral sclerosis. Neurol Neurochir Pol 2001;35:57-61.
12. Poloni M, Facchetti D, Mai R, et al. Circulating levels of tumour necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 2000;287:211-214.
13. Murakami N, McLennan IS, Nonaka I, et al. Transforming growth factor-β2 is elevated in skeletal muscle disorders. Muscle Nerve 1999;22:889-898.
14. Sekizawa T, Openshaw H, Ohbo K, et al. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J Neurol Sci 1998;154:194-199.
15. Ono S, Hu J, Shimizu N, et al. Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis. J Neuro Sci 2001;187:27-43.
16. Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 2001;57:1282-1289.
17. Almer G, Guegan C, Teismann P, et al. Increased expression of the proinflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001;49:176-185.
18. Keep M, Elmer E, Fong KS, Csiszar K. Intrathecal cyclosporin prolongs survival of late-stage ALS mice. Brain Res 2001;894:327-331.
19. Hussien Y, Sanna A, Soderstrom M, et al. Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis. J Neuroimmunol 2001;121:102-110.
20. Huang YM, Kouwenhoven M, Jin YP, et al. Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression. Mult Scler 2001;7:95-99.
21. Fischer HG, Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 2001;166:2717-2726.
22. Serafini B, Columba-Cabezas S, Di Rosa F, Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol 2000;157:1991-2002.
23. Matyszak MK, Perry VH. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 1996;74:599-608.
24. Caux C, Ait-Yahia S, Chemin K, et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 2000;22:345-369.
25. Pashenkov M, Huang YM, Kostulas V, et al. Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 2001;124:480-492.
26. Kostulas N, Li HL, Xiao BG, et al. Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 2002;33:1129-1134.
27. Pashenkov M, Teleshova N, Kouwenhoven M, et al. Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J Neuroimmunol 2002;122:106-116.
28. Tran EH, Hoekstra K, van Rooijen N, et al. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 1998;161:3767-3775.
29. Santambrogio L, Belyanskaya SL, Fischer FR, et al. Developmental plasticity of CNS microglia. Proc Natl Acad Sci USA 2001;98:6295-6300.
30. Fischer HG, Bielinsky AK. Antigen presentation function of brain-derived dendriform cells depends on astrocyte help. Int Immunol 1999;11:1265-1274.
31. Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 2000;192:899-905.
32. Izikson L, Klein RS, Charo IF, et al. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 2000;192:1075-1080.
33. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002;82:97-130.
34. Huang YM, Yang JS, Xu LY, et al. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol 2000;122:437-444.
35. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
36. Van Den Bosch L, Tilkin P, Lemmens G, Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 2002;13:1067-1070.
37. Zhu S, Stavrovskaya IG, Drozda M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002;417:74-78.
38. Kriz J, Nguyen MD, Julien JP. Minocycline delays motor neuron degeneration and slows down disease progression in a mouse model of ALS. J Neurol Sci 2002;199(suppl 1):S34.
39. Ishigaki S, Niwa J, Ando Y, et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett 2002;531:354-358.
40. Malaspina A, Kaushik N, de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 2001;77:132-145.
41. Olsen MK, Roberds SL, Ellerbrock BR, et al. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol 2001;50:730-740.
42. Yoshihara T, Ishigaki S, Yamamoto M, et al. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 2002;80:158-167.
43. Brooke GP, Sopp P, Kwong LS, Howard CJ. Molecular cloning of cattle CD63 and evidence for high level expression on subpopulations of dendritic cells. Immunogenetics 1999;49:812-814.
44. Draude G, Lorenz RL. TGF-β1 down regulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am J Physiol Heart Circ Physiol 2000;278: H1042-H1048.
45. Leveque C, Grafte S, Paysant J, et al. Regulation of interleukin 3 receptor alpha chain (IL-3R alpha) on human monocytes by interleukin (IL)-4, IL-10, IL-13, and transforming growth factor beta (TGF-beta). Cytokine 1998;10:487-494.
46. Noguera A, Batle S, Miralles C, et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001;56:432-437.
47. Uwai M, Terui Y, Mishima Y, et al. A new apoptotic pathway for the complement factor B-derived fragment Bb. J Cell Physiol 2000;185:280-292.
48. Cario E, Rosenberg IM, Brandwein SL, et al. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000;164:966-972.
49. Luk JM, Lai W, Tam P, Koo MW. Suppression of cytokine production and cell adhesion molecule expression in human monocytic cell line THP-1 by Tripterygium wilfordii polysaccharide moiety. Life Sci 2000;67:155-163.
50. Lienenluke B, Germann T, Kroczek RA, Hecker M. CD154 stimulation of interleukin-12 synthesis in human endothelial cells. Eur J Immunol 2000;30:2864-2870.
51. Kato M, Neil TK, Fearnley DB, et al. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int Immunol 2000;12:1511-1519.
52. Liu Y, Santin AD, Mane M, et al. Transduction and utility of the granulocyte-macrophage colony-stimulating factor gene into monocytes and dendritic cells by adeno-associated virus. J Interferon Cytokine Res 2000;20:21-30.
53. Lichtenberger C, Zakeri S, Baier K, et al. A novel high-purity isolation method for human peripheral blood neutrophils permitting polymerase chain reaction-based mRNA studies. J Immunol Methods 1999;227:75-84.
54. Lesnikov V, Lesnikova M, Deeg HJ. Pro-apoptotic and anti-apoptotic effects of transferrin and transferrin-derived glycans on hematopoietic cells and lymphocytes. Exp Hematol 2001;29:477-489.
55. McGuinness PH, Painter D, Davies S, McCaughan GW. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 2000;46:260-269.
56. Atkins GJ, Haynes DR, Geary SM, et al. Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone 2000;26:653-661.
57. De Rossi M, Bernasconi P, Baggi F, et al. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 2000;12:1329-1335.
58. Hatano Y, Katagiri K, Takayasu S. Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD). Clin Exp Immunol 1999;117:237-243.
59. Koller MR, Oxender M, Jensen TC, et al. Direct contact between CD34+lin-cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production. Exp Hematol 1999;27:734-741.